Insight journal - Technology

Personalized medicine: recent life science partnering trends

Posted on 08 April 2014

Tags: , , , ,

Recent advances in biomarkers, pharmacogenomics, and companion diagnostics have increased partnering trends and opportunities in the emerging field of personalized medicine.

Personalized medicine proposes customization of healthcare – with medical decisions, practices, and/or products being tailored to the individual patient – such as by use of genetic or other information.

Personalized medicine can be sub-divided into three distinct areas where biopharmaceutical intervention is concerned:

  • Biomarkers
  • Companion diagnostics
  • Pharmacogenomics

According to the Current Agreements life science deals and alliance database, around 1,000 personalized medicine partnering deals were made since 2009. The last year (2013) alone saw 234 partnering deals in this area.

The following figure shows personalized medicine partnering frequency between 2009 and 2014, where 2014 represents deals up to end March 2014.

Figure 1: Personalized medicine partnering frequency since 2009








Source: Current Agreements, 2014

It is evident that partnering activity has increased significantly since 2009 and has gained popularity as an emerging and promising technology area.

Analysis of data from Current Agreements suggests that big pharma companies are fairly active in signing deals involving personalized medicine assets. Roche heads the big pharma dealmaking to date with 29 deals followed by Pfizer, BMS, and Abbott.

Researchers and analysts can benefit from identifying the most active personalized medicine dealmakers in order to gain insight into the trends and benchmark partnering payment deal terms.

Figure 2: Most active personalized medicine dealmakers since 2009












Source: Current Agreements, 2014

As an emerging and exciting area for therapeutic intervention, personalized medicine deal making can have a high headline deal value.

The following figure shows the leading personalized medicine deals by headline value of the deal when announced between 2009 and 2014.

 Figure 3: Top personalized medicine deals by value since 2009















Source: Current Agreements, 2014

Oncology is the therapy area that personalized medicine mainly focuses upon with around 713 deals signed since 2009.

Other therapeutic focus areas in personalized medicine partnering are in cardiovascular, CNS and psychiatry.

The following figure summarizes partnering deals by therapeutic area.

Figure 4: Personalized medicine partnering by therapeutic area since 2009




















Source: Current Agreements, 2014

The future of medicine points to personalized medicine and its advancements. Extensive research towards accurate and low cost biomarkers and companion diagnostics is underway, paving way for investment of knowledge and expertise in this field.

The Personalized Medicine Partnering Terms and Agreements report published by Current Partnering provides full details of over 1000 personalized medicine deals announced since 2009 and includes average deal terms including headline, upfront, milestone and royalty rates, where available. In addition, the report provides details of deals broken down by deal type, stage of development, company A-Z and technology type. More details here


The above information has been abstracted from the following resources:

Shamini Thiagarajan



Read: more personalized medicine deals in pharma, biotech, life science partnering deal news, insights and glossary

View: glossary definition for personalized medicine

Related reportsBiomarker Partnering Terms and Agreements ; Companion Diagnostics Partnering Terms and Agreements ; Pharmacogenomics Partnering Terms and Agreements

View also: Other technology type reports

View: Current Partnering Insight Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering Insight Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering Insight Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter


Print Friendly, PDF & Email

Leave a Reply